Live from the NIH registry
Studies recruiting near Riverside right now
Top 25 of 965 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Loma Linda University Medical Center (Adults only) — Loma Linda, California (10.8 mi)
· Sponsor: Pierre Fabre Medicament
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
Children's Hospital Orange County — Orange, California (28.3 mi)
· Sponsor: New York Medical College
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Orange, California (28.3 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Loma Linda University Medical Center — Loma Linda, California (10.8 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (28.3 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (28.3 mi)
· Sponsor: University of California, Irvine
Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation
Tobacco Use, Tobacco Use Cessation
N/A
Interventional 105 participants sought
Riverside University Health Systems — Moreno Valley, California (9.4 mi)
· Sponsor: Loma Linda University
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Univ Cali Irvine ALS Neuromuscular — Orange, California (28.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
University of California, Irvine (UCI) Health - UC Irvine Medical Center — Orange, California (28.3 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of California, Irvine — Orange, California (28.3 mi)
· Sponsor: Lyell Immunopharma, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (10.8 mi)
· Sponsor: Medtronic MiniMed, Inc.
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
MemorialCare Health System — Laguna Hills, California (29.0 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
University of California Irvine — Orange, California (28.3 mi)
· Sponsor: Nurix Therapeutics, Inc.
Study of SGN1 in Patients With Advanced Solid Tumor
Advanced Solid Tumor
Phase 1, Phase 2
Interventional 70 participants sought
Health Chao Family Comprehensive Cancer Center — Orange, California (28.3 mi)
· Sponsor: Guangzhou Sinogen Pharmaceutical Co., Ltd
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
EGFR Mutant Advanced Non-small Cell Lung Cancer
Phase 1, Phase 2
Interventional 150 participants sought
Chao Family Comprehensive Cancer Center, University of California Irvine Healthcare — Orange, California (28.3 mi)
· Sponsor: J Ints Bio
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
Loma Linda University Children's Hospital - PIN — Loma Linda, California (10.8 mi)
· Sponsor: Amgen
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 216 participants sought
City of Hope Upland — Upland, California (18.2 mi)
· Sponsor: City of Hope Medical Center
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
University of California Irvine — Orange, California (28.3 mi)
· Sponsor: Regeneron Pharmaceuticals
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
University of California, Irvine — Orange, California (28.3 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
WRAP North America
Venous Stenosis, Venous Occlusion
N/A
Observational 250 participants sought
Apex Research of Riverside — Riverside, California (1.1 mi)
· Sponsor: Merit Medical Systems, Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Riverside Community Hospital — Riverside, California (1.1 mi)
· Sponsor: Duke University
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Children'S Hospital of Orange County — Orange, California (28.3 mi)
· Sponsor: Incyte Corporation
A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
Congenital Pseudarthrosis of Tibia
Phase 3
Interventional 12 participants sought
Loma Linda University Health — Loma Linda, California (10.8 mi)
· Sponsor: Novadip Biosciences
A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
Epileptic Encephalopathy
Phase 1, Phase 2
Interventional 20 participants sought
Children's Hospital of Orange County — Orange, California (28.3 mi)
· Sponsor: Institut de Recherches Internationales Servier
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — Laguna Hills, California (29.0 mi)
· Sponsor: Salma Health, Inc.